Company and its subsidiary for Quarter 3 of 2019 ending on 30 September 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical

operating result for the year of 2019 The company’s net profit was Baht 725.51 million, representing an increase of 65.4% over the year of 2018 and total revenue was Baht 17,971.82 million, representing a

(separate financial statement) 31-へ綺ar-19 31-ヽlar-18 31-Mar-19 31-Mar-18 (Mill:on 3ahi) % Revenue fi^om Sales 47.31 50.24 41.97 45.53 (3_56) (7.32) Other ,Revenue 1.64 0.57 1.60 0.44 1.16 263.64 Total Revenue

in the table below: Revenue from Sales In 2Q20, the Company’s total revenue from sales was Baht 339.34 million, which increased by Baht 129.20 million or 61.48% when compared with the same period in

.The company and its subsidiaries had revenue from sales and services shown in the consolidated financial statements for the 2nd quarter of 2020 amounted of Baht 238.33 million, a decrease compared to

offsetting such discount. In 2Q20, The Company, with full impact from COVID-19, reported total revenue of THB 927m, decreased by 61% YoY. The major drivers of such decline were 51% drop in revenue from sales

subsidiary for Quarter 1 of 2020 ending on 31 March 2020 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for the 1st

of 122.79 million baht, a decrease of 103.79 million baht or 45.81% compared to the same period of the previous year due to: 1.1 Revenue from Sales of 6.25 million baht, a decrease of 4.09 million baht

the previous year equal to 63.78 million baht, The company would like to clarify the important changes as follows: 1. Total revenue of the group of companies for the year 2020 has total income of 122.79

ต้นทุนค่าเสื่อมราคาและค่าตัดจ าหน่าย Operating highlight in Q2/2018 Q2/17 Q1/18 Q2/18 Change +/(-) 1H/17 1H/18 Change +/(-) (THB million) QoQ YoY YoY Operating revenue 5,459 5,716 6,563 15% 20% 10,825